ASRS 2023: Prior Authorization Requests for Anti-VEGF Medications Often Delayed Despite Overwhelming Approval Rates
Researchers say the utility of these prior authorizations should be reconsidered
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.